Key result
Deficient Cdc42Hs impairs cellular cholesterol efflux in Tangier disease models.
Answers are grounded in this paper and cite their sources.
Cholesterol efflux (CE) is the initial and important step of reverse cholesterol transport (RCT), a major protective system against atherosclerosis. However, most of the molecular mechanism for CE still remains to be clarified. In the present study, cDNA subtraction revealed that the expression of a member of the Rho GTPase family, Cdc42Hs, was markedly decreased in both passaged fibroblasts and macrophages (Mφ) from patients with Tangier disease (TD), a rare lipoprotein disorder with reduced CE. This small G protein is known to have many cell biological activities such as rearrangement of actin cytoskeleton and vesicular transport, however the association between this molecule and lipid transport has never been reported. We demonstrate that MDCK cells expressing the dominant negative form of Cdc42Hs had reduced CE, inversely ones expressing the dominant active form had increased CE. From these observations, we would like to raise a novel hypothesis that this type of small G protein may play a role in some steps of CE. To our knowledge, the present study is the first demonstration that the expression of this molecule is altered in cells from human disease.
No takes yet. Share an insight, caveat, or question.
Hirano et al. (2000) studied Tangier disease. Cdc42Hs expression (dominant negative vs dominant active forms) vs. Normal cells / opposite Cdc42Hs activity form was evaluated on Cholesterol efflux (CE) and Cdc42Hs expression. Cdc42Hs expression was markedly decreased in fibroblasts and macrophages from Tangier disease patients, and expressing dominant negative Cdc42Hs in MDCK cells reduced cholesterol efflux.
Synapse has enriched 10 related papers. Consider them for comparative context: